Table 4.
Univariate and multivariate analyses of overall survival.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p-value | HR | 95% CI | p-value | |
| Age (years) | ||||||
| <60 (n = 336) | Ref | Ref | ||||
| ≥60 (n = 338) | 1.25 | 0.94–1.68 | 0.123 | 1.39 | 1.03–1.87 | 0.030 |
| Sex | ||||||
| Female (n = 330) | Ref | Ref | ||||
| Male (n = 344) | 1.09 | 0.81–1.45 | 0.576 | 1.18 | 0.88–1.58 | 0.274 |
| TMB | ||||||
| Low (n = 555) | Ref | Ref | ||||
| High (n = 119) | 0.57 | 0.40–0.82 | 0.012 | 0.60 | 0.38–0.94 | 0.026 |
| Primary tumor location | ||||||
| Left (n = 388) | Ref | Ref | ||||
| Right (n = 286) | 1.13 | 0.84–1.51 | 0.417 | 1.17 | 0.87–1.57 | 0.294 |
| Stage at diagnosis | ||||||
| I (n = 48) | Ref | Ref | ||||
| II (n = 124) | 1.11 | 0.34–3.65 | 0.867 | 0.97 | 0.28–3.34 | 0.959 |
| III (n = 172) | 1.84 | 0.74–4.58 | 0.299 | 2.00 | 0.62–6.49 | 0.245 |
| IV (n = 330) | 2.29 | 1.05–5.00 | 0.142 | 2.46 | 0.78–7.77 | 0.125 |
TMB, tumor mutation burden; HR, hazard ratio; CI, confidence interval.